Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Jinling Hospital, China
Jinling Hospital, China
Ludwig-Maximilians - University of Munich
Zhujiang Hospital
Medical University of Graz
Royal Marsden NHS Foundation Trust
IRCCS San Raffaele